Interferon α in the treatment of chronic hepatitis C in children: A metanalysis

Journal of Viral Hepatitis

Volumn 10, Issue 3, 2003, Pages 210-214

  Di Ciommo, Vincenzo ^a   Russo, P ^b   Rava L ^a   Caprino, L ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Children; Chronic hepatitis; Hepatitis C virus; Interferon alpha; Metanalysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONVULSION; DRUG EFFICACY; EMBASE; FLU LIKE SYNDROME; HAIR LOSS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LIVER BIOPSY; MEDLINE; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; INTERFERON-ALPHA; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0038579864     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00420.x     Document Type: Article

References (39)

1. Anonymous. EASL International Consensus Conference on Hepatitis C. Consensus Statement. J Hepatology 1999; 30: 956-961.
2. Romano L, Azara A, Chiaramonte M et al. Low prevalence of anti-HCV antibody among Italian children. Infection 1994; 22: 350-352.
3. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26(Suppl. 1): 14S-19S.
4. Cammà C, Giunta M, Pinzello G et al. Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol 1999; 94: 581-595.
5. Bennett WG, Inoue Y, Beck JR et al. Estimates of the cost-effectiveness of a single course of interferon-α2b in patients with a histologically mild chronic hepatitis C. Ann Intern Med 1997; 127: 855-865.
6. Madhumita S, Ananya D. Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children. Pediatr Infect Dis J 2000; 19: 23-30.
7. Torte D, Tambini R. Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis. Clin Infect Dis 1996; 23: 131-137.
8. Jacobson KR, Murray K, Zellos A et al. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. JPGN 2002; 34: 52-58.
9. Guido M, Rugge M, Jara P et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998; 115: 1525-1529.
10. Majda-Stanislawska. Clinical picture of chronic hepatitis C in children. Polish experience. Acta Gatroenterol Belg 2001; 64: 20-24.
11. Pagliaro L. Craxi A, Camma C et al. Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology 1994; 19: 820-828.
12. Rosenthal P. Chronic hepatitis C viral infection in childhood: to treat or not to treat with interferon - that is the question. J Pediatr Gastroenterol Nutr 1997; 24: 363-364.
13. Mother D, Cook DJ, Eastwood S et al. Improving the quality of reports of meta-analysis of randomized controlled trials: the QUORUM statement. Lancet 1999; 354: 1896-1900.
14. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. 2nd edn. New York: Oxford University Press, 2000.
15. Ruiz-Moreno M, Rua MJ, Castillo I et al. Treatment of children with chronic hepatitis C with recombinant interferon-α. Hepatology 1992; 16: 882-885.
16. Clemente MG, Congia M, Lai ME et al. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis. C J Pediatr 1994; 125: 123-128.
17. Marcellini M, Kondili LA, Comparcola D et al. High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease. Pediatr Infect Dis J 1997; 16: 1049-1053.
18. Zwiener RJ, Fielman BA, Cochran C et al. Interferon-alpha-2b treatment of chronic hepatitis C in children with hemophilia. Pediatr Infect Dis J 1996; 15: 906-908.
19. Matsuoka S, Mori K. Nakano O et al. Efficacy of interferon in treating children with chronic hepatitis C. Eur J Pediatr 1997; 156: 704-708.
20. Fujisawa T, Inui A, Ohkawa T et al. Response to interferon therapy in children with chronic hepatitis C. J Pediatr 1995; 127: 660-662.
21. Fujisawa T, Inui A, Komatsu H et al. Interferon-alpha therapy for children with chronic hepatitis C. Zhoghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1998; 39: 146-149.
22. Jonas MJ, Ott MJ, Nelson SP et al. Interferon-alpha treatment of chronic hepatitis C virus infection in children. Pediatr Infect Dis J 1998; 17: 241-246.
23. Pensati P, Iorio R, Botta S et al. Low virological response to interferon in children with chronic hepatitis C. J Hepatol 1999: 31: 604-611.
24. Yuce A, Kocak N. Gurakan F et al. Interferon-alpha treatment for chronic hepatitis C in children. Turk J Pediatr 2000; 42: 34-38.
25. Sawada A, Tajiri H, Kozaiwa K et al. Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C. J Hepatol 1998; 28: 184-188.
26. Spiliopoulou I, Repanti M, Katinakis S et al. Response to interferon alfa-2b therapy in multitransfused children with beta-thalassemia and chronic hepatitis C. Eur J Clin Microbiol Infect Dis 1999; 18: 709-715.
27. Cesaro S, Bortolotti F, Petris MG et al. Interferon treatment of chronic hepatitis C in patients cured of pediatric malignancies. Haematologica 2000; 85: 63-66.
28. Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children. Med Sci Monitor 2000; 6: 964-970.
29. Majda-Stanislawska E, Szaflik I, Omulecka A. Interferon alpha for eradication of HCV and remission of chronic hepatitis in children. Med Sci Monit 2000; 6: 1142-1147.
30. Prati D, Zanella A. Zanuso F et al. Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group. J Viral Hepat 2000; 7: 352-360.
31. Bortolotti F, Giacchino R, Vajro P et al. Recombinant Interferon Alfa therapy in children with chronic hepatitis C. Hepatology 1995; 22: 1623-1627.
32. Iorio R, Pensati P, Porzio S et al. Lymphoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child 1996; 74: 152-156.
33. Epistat [computer program]. Version 5.0. Richardson (Texas): TL Gustafson. 1995.
34. Dixon RA, Munro JF, Silcocks PB. The evidence-based medicine workbook. Critical appraisal for clinical problem solving. Oxford: Butterworth-Heinemann, 1997: 108.
35. Iorio R, Pensati P, Botta S et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997; 16: 984-990.
36. Torre D, Tambini R. Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis. Clinical Infectious Diseases 1996: 23: 131-137.
37. Vogt M, Lang T, Frosner G et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Eng J Med 1999; 341: 866-870.
38. Wiese M, Bert F, Lafrenz M et al. Low frequency of cirrhosis in a hepatitis C (Genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000; 32: 91-96.
39. Kenny-Walsh E (The Irish Hepatology Research Group). Clinical outcomes after hepatitis C infection from contaminated anti-D immuneglobulin. N Engl J Med 1999: 1228-1233.